Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
105.26
-0.01 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
105.27
0.01%
After-hours: Aug 15, 2025, 04:15 PM EDT
Verona Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 118.53M | 42.28M | 6.56M | 940.06K | 940.06K | 940.06K | 458K | 458K | 458K | 458K | n/a | 40M | 40M | 40M | 40M | n/a | n/a |
Cost of Revenue | 6.26M | 3.12M | 1.29M | 897.06K | 784.26K | 679.84K | 816.03K | 817.59K | 823.65K | 665.23K | 319.23K | 163.56K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 112.28M | 39.16M | 5.28M | 43K | 155.79K | 260.22K | -358.03K | -359.59K | -365.65K | -207.23K | -319.23K | 39.84M | 40M | 40M | 40M | n/a | n/a |
Operating Income | -137.82M | -154.69M | -155.61M | -129.67M | -71.14M | -66.16M | -61.15M | -61.55M | -72.09M | -74.95M | -89.17M | -67.48M | -75.52M | -73.31M | -72.89M | -100.61M | -82.55M |
Interest Income | 15.79M | 15.26M | 14.59M | 13.23M | 13.49M | 12.79M | 11.33M | 8.72M | 5.48M | 2.82M | 962K | 187K | 25K | 14K | 16K | 25K | 56K |
Pretax Income | -155.57M | -164.63M | -154.42M | -126.35M | -64.1M | -55.06M | -50.13M | -51.07M | -60.26M | -68.45M | -81.54M | -54.78M | -59.13M | -55.59M | -49.97M | -83.3M | -72.06M |
Net Income | -164.02M | -173.48M | -153.91M | -125.64M | -63.53M | -54.49M | -50.69M | -51.65M | -60.61M | -68.7M | -81.51M | -54.81M | -59.12M | -55.57M | -56.04M | -86.96M | -73.94M |
Selling & General & Admin | 198.21M | 149.26M | 119.07M | 97.22M | 60.84M | 50.27M | 43.7M | 35.64M | 28.73M | 26.58M | 24.01M | 29.61M | 32.06M | 33.91M | 39.84M | 37.41M | 32.28M |
Research & Development | 51.89M | 44.59M | 40.88M | 33.29M | 11.4M | 17.25M | 19.93M | 26.81M | 44.27M | 49.28M | 65.15M | 77.88M | 83.46M | 79.41M | 73.05M | 63.2M | 50.27M |
Other Expenses | 270.3K | 270.3K | 270.3K | 270.3K | n/a | -2.31M | -3.11M | -5.24M | -10.64M | -9.63M | -13.81M | -16.43M | -14.86M | -15.63M | -18.92M | -14.17M | -10.34M |
Operating Expenses | 250.1M | 193.85M | 159.95M | 130.51M | 74.18M | 67.15M | 62.46M | 59.15M | 62.35M | 66.23M | 75.35M | 91.05M | 100.66M | 97.68M | 93.97M | 86.44M | 72.21M |
Interest Expense | 11.78M | 23.54M | 13.85M | 4.37M | 3.36M | 2.06M | 1.66M | 1.38M | 730K | 521K | 376K | 346K | 340K | 340K | -1.15M | -1.23M | -1.32M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 1.13M | 1.13M | 1.13M | 1.13M | -11.51M | -11.51M | -11.51M | -11.51M | n/a | n/a | n/a |
Cost & Expenses | 256.36M | 196.97M | 161.23M | 131.25M | 74.65M | 67.36M | 62.81M | 59.5M | 62.7M | 66.57M | 75.35M | 91.05M | 100.66M | 97.68M | 93.97M | 86.44M | 72.21M |
Income Tax Expense | 8.45M | 8.86M | -510.37K | -804.37K | -661.55K | -657.46K | 467K | 575K | 344K | 253K | -25K | 38K | -16K | -18K | 6.08M | 3.66M | 1.88M |
Shares Outstanding (Basic) | 84.93M | 81.54M | 81.49M | 81.03M | 80.71M | 59.12M | 79.78M | 79.31M | 77.68M | 75.53M | 65.2M | 60.6M | 60.24M | 59.9M | 69.07M | 58.85M | 58.68M |
Shares Outstanding (Diluted) | 84.93M | 81.54M | 81.49M | 81.03M | 80.71M | 80.27M | 79.78M | 79.31M | 77.68M | 75.53M | 68.02M | 60.6M | 60.24M | 59.9M | 64.48M | 58.85M | 58.68M |
EPS (Basic) | -2 | -2.16 | -2 | -1.6 | -0.88 | -0.75 | -0.65 | -0.7 | -0.88 | -1.12 | -1.36 | -0.96 | -1.04 | -0.96 | -1.04 | -1.6 | -1.92 |
EPS (Diluted) | -2 | -2.16 | -1.92 | -1.6 | -0.79 | -0.69 | -0.65 | -0.7 | -0.88 | -1.04 | -1.36 | -0.96 | -1.04 | -0.96 | -0.96 | -1.6 | -1.92 |
EBITDA | -176.07M | -193.17M | -124.96M | -103.93M | -59.03M | -51.83M | -47.84M | -49.47M | -53.4M | -55.37M | -69.94M | -43.38M | -48.87M | -45.87M | -40.44M | -70.59M | -61.7M |
EBIT | -122.52M | -139.59M | -137.91M | -119.32M | -59.02M | -51.84M | -48.47M | -49.69M | -59.53M | -67.93M | -81.16M | -54.43M | -58.79M | -55.25M | -51.11M | -81.26M | -68.33M |
Depreciation & Amortization | 1.09M | 1.06M | 1.01M | 896.3K | 783K | 677K | 620K | 622K | 630K | 636K | 647K | 652K | 639K | 629K | 502K | 548.88K | 587.98K |